Health Catalyst Inc. (HCAT)
The price, the headline numbers and the latest news, in one place.
Health Catalyst Inc. (HCAT) Stock Price, Analysis & Data
| Bid | 1.16 |
| Market Cap | 115.14M |
| Revenue (ttm) | 292.24M |
| Net Income (ttm) | -264.82M |
| 1.56 | |
| -3.68 | |
| n/a | |
| 194.9 | |
| P/B (ttm) | 1.13 |
| P/S (ttm) | 0.39 |
| Earnings Date | Aug 5, 2021 |
| Ask | 1.99 |
| Volume | 1,062,709 |
| Avg. Volume (20D) | 1,666,916 |
| Open | 1.61 |
| Previous Close | 1.63 |
| Day's Range | 1.53 - 1.61 |
| 52-Week Range | 0.95 - 3.80 |
| Analyst | Hold |
| Price Target | 1.9 (24.18%) |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About HCAT
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. The company operates in two segments: Technology and Professional Services. It offers ignite data and analytics platform that provides clients a single comprehensive environment to integrate and organize data from their disparate software systems; and applications, a software analytics applications build for ignite platform ...
Financial Performance
In 2025, Health Catalyst's revenue was 311.14M, an increase of 1.48% compared to the previous year's 306.58M. Earnings were -177.97M, an increase of 156.07%.
Financial StatementsAnalyst Forecast
According to 4 analyst ratings, the average rating for HCAT stock is "Hold". The 12-month stock price forecast is 1.9, which is upside of 24.18% from the latest price.
Stock ForecastsEarnings Surprise
- Revenue of $70.49M misses estimates by $0, with -12.68% YoY decline.
- EPS of 0.04 exceeds estimates by 0.01, with 0.00% YoY growth.
Analysts project revenue of ... Upgrade
